Drugs

NuPathe Appoints Bart J. Dunn as Vice President, Corporate Development & Licensing

CONSHOHOCKEN, PA: ...

Theravance to Present at Investor Conferences in November 2011

SOUTH SAN FRANCISCO, CA: ...

Cytokinetics Announces Initiation of Second Cohort of Ongoing Phase II Clinical Trial Evaluating CK-2017357 in Patients With ALS

SOUTH SAN FRANCISCO, CA: ...

IBC Life Sciences Kicks Off the Annual BioProcess International(TM) Conference & Exhibition in Long Beach, California

WESTBOROUGH, MA: ...

Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call

LYON, FRANCE: ...

Taconic and Oncodesign(R) Announce Agreement to Co-Promote and Co-Develop Solutions to Advance Oncology Research

HUDSON, NY and DIJON, FRANCE: ...

International Journal of Radiation Oncology, Biology and Physics Publishes Cleveland BioLabs Study of CBLB502 Protection From Radiation Dermatitis and Oral Mucositis in Head and Neck Cancer Model

BUFFALO, NY: ...

Critical Outcome Technologies Inc. Announces Warrant Term Amendments

LONDON, ONTARIO: ...

Late Stage Drugs From BioSante and AEterna Zentaris Could Reawaken Interest in Biotech Sector

NEW YORK, NY: The Paragon Report Provides Equity Research on BioSante Pharmaceuticals & AEterna Zentaris ...

PharmStar Outstanding Common Stock Reduced by 50%

WILSON, NC: ...